While AHCY is a potential target for tumor therapy, BHB inhibits AHCY through Kbhb modification of the rate-limiting methionine cyclase AHCY K188, K389, K405, site-inhibit AHCY activity (30). This evidence concerns the gene AHCY and neoplasm.